Contact this trialFirst, we need to learn more about you.
ERK Inhibitor
ASTX029 +1 More for Myelodysplastic syndromes
Recruiting1 awardPhase 1 & 2
Houston, Texas
This trial aims to determine the highest safe dose of ASTX029 that can be given with ASTX727 to patients with specific types of blood disorders. The second part of the study will investigate if this
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.